RESUMO
Role of genetic factors in etiology of preeclampsia is not confirmed yet. Gene defect frequency varies in different geographic areas as well as ethnic groups. In this study, the role of factor V Leiden mutation in the pathogenesis of preeclamsia syndrome among the pregnant population of northern shore of Persian Gulf in Iran, were considered. Between Jan. 2008 and Dec. 2009, in a nested case control study, pregnant women with preeclamsia [N=198] as cases and healthy [N=201] as controls were enrolled in the study. DNA were extracted from 10 CC peripheral blood and analyzed for presence of factor V Leiden mutation in these subjects. The maternal and neonatal outcomes of pregnancy according to the distribution of factor V Leiden were also compared among cases. In total, 17[8.6%] of cases and 2 [1%] of controls showed the factor V Leiden mutation. The incidence of factor V Leiden was typically higher in preeclamsia women than control group [OR: 9.34%95 CI: 21.12-41.01]. There was no difference in incidence rate of preterm delivery <37 weeks [OR: 1.23%95 CI: 0.38-4.02], very early preterm delivery <32 weeks [OR: 1.00%95 CI: 0.12-8.46], intra uterine fetal growth restriction [IUGR] [OR: 1.32%95 CI: 0.15-1130], and the rate of cesarean section [OR: 0.88%95 CI: 0.29-2.62] among cases based on the prevalence of factor V Leiden mutation. The pregnant women with factor V Leiden mutation are prone for preeclampsia syndrome during pregnancy, but this risk factor was not correlated to pregnancy complications in the studied women